Internal restructuring
Vlaams Gewest; Prov. Antwerpen; Arr. Turnhout
Location of affected unit(s)
Beerse, Geel, Olen
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

318 - 482 jobs
Number of planned job losses
Job loss
Announcement Date
3 November 2009
Employment effect (start)
1 January 2010
Foreseen end date
1 January 2013


On 3rd November, pharmaceutical company Janssen Phamaceutica announced its intention to cut 558 jobs in the next three to four years at three of its Flemish sites (Beerse, Geel and Olen). Some 318 jobs will be cut in 2010. "New drugs are facing rapid and intense competition" said Tom Heyman, executive director of Janssen Phamaceutica. He also said that the revenues from new HIV treatments was insufficient to cover the shortfall arising from expiring patents and price competition. This is the fourth restructuring at the company in seven years. The number of job losses was reduced to 482 when the second notification of redundancy was announced in February 2010.

The parent company of the pharmaceutical company, the American company Johnson and Johnson, has also recently announced job cuts worldwide.  


  • 4 November 2009: L'Echo
  • 4 November 2009: Le Soir


Eurofound (2009), Janssen Pharmaceutica, Internal restructuring in Belgium, factsheet number 69892, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69892.